Maravai Lifesciences Holdings (MRVI) Inventory (2020 - 2026)
Maravai Lifesciences Holdings (MRVI) posted quarterly Inventory of $40.5 million for Q1 2026, down 18.71% year-over-year from $49.8 million in Q1 2025, and little changed quarter-over-quarter from $40.5 million in Q4 2025.
Maravai Lifesciences Holdings (MRVI) Inventory (2020 - 2026) Analysis & Trends
Maravai Lifesciences Holdings' Inventory history runs 7 years deep, the most recent figure standing at $40.5 million for Q1 2026.
- In Q1 2026, Inventory fell 18.71% year-over-year to $40.5 million; the TTM figure through Mar 2026 stood at $40.5 million (down 18.71% YoY), while the FY2025 annual figure was $40.5 million, down 19.14% from the prior year.
- Inventory for Q1 2026 stood at $40.5 million, roughly flat from $40.5 million in the prior quarter.
- The five-year high for Inventory was $62.4 million in Q3 2022, with the low at $40.5 million in Q1 2026.
- The 5-year median for Inventory is $49.8 million (2025), against an average of $49.6 million.
- The sharpest annual moves came in 2022 and 2023: Inventory grew 25.81% in 2022, then retreated 21.28% in 2023.
- Maravai Lifesciences Holdings' Inventory stood at $43.2 million in 2022, then climbed by 19.11% to $51.4 million in 2023, then declined by 2.56% to $50.1 million in 2024, then declined by 19.14% to $40.5 million in 2025, then slipped by 0.08% to $40.5 million in 2026.
- Business Quant data shows MRVI's Inventory at $40.5 million in Q1 2026, $40.5 million in Q4 2025, and $45.3 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Inventory (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | 1.77 Bn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 3.08 Bn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | 371.00 Mn |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | - |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 732.60 Mn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | 358,916.96 |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | - |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | 97.11 Mn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | 142.38 Mn |
| 10 | Maravai Lifesciences Holdings | 1.48 Bn | 1.56 Bn | 20.65 Mn | 41.23 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 41.23 Mn |
| Mar 31, 2026 | 40.46 Mn |
| Dec 31, 2025 | 40.50 Mn |
| Sep 30, 2025 | 45.33 Mn |
| Jun 30, 2025 | 46.67 Mn |
| Mar 31, 2025 | 49.77 Mn |
| Dec 31, 2024 | 50.08 Mn |
| Sep 30, 2024 | 50.53 Mn |
| Jun 30, 2024 | 49.34 Mn |
| Mar 31, 2024 | 49.85 Mn |
| Dec 31, 2023 | 51.40 Mn |
| Sep 30, 2023 | 49.14 Mn |
| Jun 30, 2023 | 47.40 Mn |
| Mar 31, 2023 | 54.82 Mn |
| Dec 31, 2022 | 43.15 Mn |
| Sep 30, 2022 | 62.42 Mn |
| Jun 30, 2022 | 60.11 Mn |
| Mar 31, 2022 | 51.41 Mn |
| Dec 31, 2021 | 51.56 Mn |
| Sep 30, 2021 | 56.25 Mn |